Abstract
Penile reconstruction may be required under some conditions such as penile malignancy, trauma, congenital genitourinary anomalies, and Peyronie’s disease (PD). The traditional penile reconstructive procedures cannot fulfill to restore a functionally and cosmetically satisfactory penis and have complications such as immunological rejection and psychological problems. One of the major structures of the penis is the corpus cavernosum. The penile corpus cavernosum is composed of sinusoids that are surrounded by the layers of endothelial cells (ECs) and smooth muscle cells (SMCs). Erectile function of penile corpus cavernosum is dependent on these two kinds of cells [1]. The therapeutic uses of stem cells (SCs) and tissue engineering (TE) techniques are emerging in urology. SCs are undifferentiated cells capable of proliferation, self-renewal, and differentiation into different cell types including ECs, SMCs, Schwann cells, and neurons [2]. SC therapy for penile tissue regeneration (TE) might replenish the depleted ECs and SMCs. Therefore, TE for penile tissue regeneration using SCs may have a huge potential and could be a novel treatment option for ideal penile reconstruction.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science. 1992;257(5068):401–3.
Lin CS, Xin ZC, Deng CH, Ning H, Lin G, Lue TF. Recent advances in andrology-related stem cell research. Asian J Androl. 2008;10(2):171–5. doi:10.1111/j.1745-7262.2008.00389.x.
Brehmer B, Rohrmann D, Becker C, Rau G, Jakse G. Different types of scaffolds for reconstruction of the urinary tract by tissue engineering. Urol Int. 2007;78(1):23–9. doi:10.1159/000096930.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663–76. doi:10.1016/j.cell.2006.07.024.
Jackson L, Jones DR, Scotting P, Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med. 2007;53(2):121–7.
Urish K, Kanda Y, Huard J. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: potential for tissue regeneration. Curr Top Dev Biol. 2005;68:263–80. doi:10.1016/S0070-2153(05)68009-X.
Hwang JH, Yuk SH, Lee JH, Lyoo WS, Ghil SH, Lee SS, Khang IG, Paik SY, Lee JY. Isolation of muscle derived stem cells from rat and its smooth muscle differentiation [corrected]. Mol Cells. 2004;17(1):57–61.
Nolazco G, Kovanecz I, Vernet D, Gelfand RA, Tsao J, Ferrini MG, Magee T, Rajfer J, Gonzalez-Cadavid NF. Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int. 2008;101(9):1156–64. doi:10.1111/j.1464-410X. 2008.07507.x.
Ji C, Min F, Liang W, Chen Y, Pan S, Bin L, Chen S, Wei Z, He T, Gu Y, Zhang J. Construction of tissue-engineered corpus cavernosum with muscle-derived stem cells and transplantation in vivo. BJU Int. 2011;107(10):1638–46. doi:10.1111/j.1464-410X. 2010.09695.x.
Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, Mytinger J, Cao B, Gates C, Wernig A, Huard J. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol. 2002;157(5):851–64. doi:10.1083/jcb.200108150.
Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol. 1998;142(5):1257–67.
An G, Ji C, Wei Z, Chen H, Zhang J. Engineering of corpus cavernosum using vascular endothelial growth factor-expressing muscle-derived stem cells seeded on acellular corporal collagen matrices. Urology. 2013;81(2):424–31. doi:10.1016/j.urology.2012.10.042.
Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005;111(2):150–6. doi:10.1161/01.CIR.0000151812.86142.45.
Song YS, Lee HJ, Park IH, Kim WK, Ku JH, Kim SU. Potential differentiation of human mesenchymal stem cell transplanted in rat corpus cavernosum toward endothelial or smooth muscle cells. Int J Impot Res. 2007;19(4):378–85. doi:10.1038/sj.ijir.3901539.
Ryu JK, Kim DH, Song KM, Yi T, Suh JK, Song SU. Intracavernous delivery of clonal mesenchymal stem cells restores erectile function in a mouse model of cavernous nerve injury. J Sex Med. 2014;11(2):411–23. doi:10.1111/jsm.12380.
Clewes O, Narytnyk A, Gillinder KR, Loughney AD, Murdoch AP, Sieber-Blum M. Human epidermal neural crest stem cells (hEPI-NCSC) – characterization and directed differentiation into osteocytes and melanocytes. Stem Cell Rev. 2011;7(4):799–814. doi:10.1007/s12015-011-9255-5.
Narytnyk A, Verdon B, Loughney A, Sweeney M, Clewes O, Taggart MJ, Sieber-Blum M. Differentiation of human epidermal neural crest stem cells (hEPI-NCSC) into virtually homogenous populations of dopaminergic neurons. Stem Cell Rev. 2014;10(2):316–26. doi:10.1007/s12015-013-9493-9.
Sieber-Blum M, Hu Y. Epidermal neural crest stem cells (EPI-NCSC) and pluripotency. Stem Cell Rev. 2008;4(4):256–60. doi:10.1007/s12015-008-9042-0.
Achilleos A, Trainor PA. Neural crest stem cells: discovery, properties and potential for therapy. Cell Res. 2012;22(2):288–304. doi:10.1038/cr.2012.11.
Le Douarin NM, Creuzet S, Couly G, Dupin E. Neural crest cell plasticity and its limits. Development. 2004;131(19):4637–50. doi:10.1242/dev.01350.
Youn YH, Feng J, Tessarollo L, Ito K, Sieber-Blum M. Neural crest stem cell and cardiac endothelium defects in the TrkC null mouse. Mol Cell Neurosci. 2003;24(1):160–70.
Trentin A, Glavieux-Pardanaud C, Le Douarin NM, Dupin E. Self-renewal capacity is a widespread property of various types of neural crest precursor cells. Proc Natl Acad Sci U S A. 2004;101(13):4495–500. doi:10.1073/pnas.0400629101.
Song YS, Lee HJ, Park IH, Lim IS, Ku JH, Kim SU. Human neural crest stem cells transplanted in rat penile corpus cavernosum to repair erectile dysfunction. BJU Int. 2008;102(2):220–4. doi:10.1111/j.1464-410X.2008.07469.x; discussion 224.
Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249–60. doi:10.1161/01.res.0000265074.83288.09.
Knoll LD. Use of small intestinal submucosa graft for the surgical management of Peyronie’s disease. J Urol. 2007;178(6):2474–8. doi:10.1016/j.juro.2007.08.044. discussion 2478.
Ma L, Yang Y, Sikka SC, Kadowitz PJ, Ignarro LJ, Abdel-Mageed AB, Hellstrom WJ. Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction. Proc Natl Acad Sci U S A. 2012;109(6):2090–5. doi:10.1073/pnas.1113810109.
Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, Montorsi F, De Ridder D, Albersen M. Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie’s disease. Eur Urol. 2013;63(3):551–60. doi:10.1016/j.eururo.2012.09.034.
Bochinski D, Lin GT, Nunes L, Carrion R, Rahman N, Lin CS, Lue TF. The effect of neural embryonic stem cell therapy in a rat model of cavernosal nerve injury. BJU Int. 2004;94(6):904–9. doi:10.1111/j.1464-410X.2003.05057.x.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Park, H.J., Moon, K.H. (2016). Modified Tissue Engineering Techniques Using Stem Cells. In: Park, N., Kim, S., Moon, D. (eds) Penile Augmentation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46753-4_25
Download citation
DOI: https://doi.org/10.1007/978-3-662-46753-4_25
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46752-7
Online ISBN: 978-3-662-46753-4
eBook Packages: MedicineMedicine (R0)